We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.65B
AUM Growth
+$68.2M
(+2.6%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
3.99%
Top 10 Holdings %
Top 10 Hldgs %
43.52%
Holding
66
New
14
Increased
16
Reduced
21
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$122M |
| 2 |
Zimmer Biomet
ZBH
|
+$96.2M |
| 3 |
Baxter International
BAX
|
+$88.2M |
| 4 |
Biogen
BIIB
|
+$83.1M |
| 5 |
Labcorp
LH
|
+$80.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$161M |
| 2 |
Elanco Animal Health
ELAN
|
+$97.3M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$82M |
| 4 |
AMRN
Amarin Corp
AMRN
|
+$59.1M |
| 5 |
Align Technology
ALGN
|
+$56.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.28% |
| 2 | Technology | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Personalis
PSNL
$1.44B
| $4.16M | 0.16% |
283,500
-16,500
| -6% | -$312K |
|
|
PTE
52
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $2.06M | 0.08% |
25,444
+2,444
| +11% | +$280K |
|
53
Acadia Pharmaceuticals
ACAD
$4.65B
| – | – |
-119,484
| Closed | -$3.19M |
|
54
Adaptive Biotechnologies
ADPT
$3.9B
| – | – |
-120,000
| Closed | -$5.8M |
|
|
55
Align Technology
ALGN
$12.4B
| – | – |
-205,510
| Closed | -$56.2M |
|
56
Alnylam Pharmaceuticals
ALNY
$29.3B
| – | – |
-468,540
| Closed | -$34M |
|
|
AMRN
57
Amarin Corp
AMRN
$302M
| – | – |
-152,396
| Closed | -$59.1M |
|
58
Becton Dickinson
BDX
$46.9B
| – | – |
-124,302
| Closed | -$30.6M |
|
59
Centene
CNC
$31.7B
| – | – |
-250,000
| Closed | -$13.1M |
|
|
60
Elanco Animal Health
ELAN
$12.8B
| – | – |
-2,879,010
| Closed | -$97.3M |
|
61
Elevance Health
ELV
$82B
| – | – |
-151,220
| Closed | -$42.7M |
|
62
Ironwood Pharmaceuticals
IRWD
$709M
| – | – |
-500,000
| Closed | -$5.47M |
|
63
PUT
Pfizer
PFE
$145B
| – | – |
-527,000
| Closed | -$21.7M |
|
64
Tenet Healthcare
THC
$20.4B
| – | – |
-425,820
| Closed | -$8.8M |
|
|
AXLA
65
DELISTED
Axcella Health Inc. Common Stock
AXLA
| – | – |
-6,826
| Closed | -$1.59M |
|
|
RDUS
66
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-1,242,850
| Closed | -$30.3M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2019 Portfolio in Review
As of Q3 2019, HealthCor Management held 66 positions worth $2.65B, up 2.6% from $2.58B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
HealthCor Management deployed $105M of net new capital in Q3 2019, opening 14 new positions and adding to 16 existing holdings. Its largest new stake was Intuitive Surgical: 705,615 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Technology.
On the sell side, the largest reduction was Humana, an estimated $161M trimmed.
- HealthCor Management's largest Q3 2019 buy was Intuitive Surgical: 705,615 shares worth $127M.
- HealthCor Management added most to Wright Medical Group Inc in Q3 2019, an estimated $46.7M increase.
- HealthCor Management's biggest Q3 2019 reduction was Humana, cutting an estimated $161M.
- HealthCor Management fully exited Elanco Animal Health in Q3 2019, selling an estimated $97.3M.
- HealthCor Management's ten largest holdings make up 44% of its $2.65B portfolio in Q3 2019.
- HealthCor Management opened 14 new positions and closed 14 in Q3 2019.
- HealthCor Management's portfolio value rose 2.6% quarter-over-quarter to $2.65B.
Based on HealthCor Management's 13F filing for Q3 2019, filed 14 Nov 2019.